199 related articles for article (PubMed ID: 26609053)
1. Aberrant Activation of Notch Signaling Inhibits PROX1 Activity to Enhance the Malignant Behavior of Thyroid Cancer Cells.
Choi D; Ramu S; Park E; Jung E; Yang S; Jung W; Choi I; Lee S; Kim KE; Seong YJ; Hong M; Daghlian G; Kim D; Shin E; Seo JI; Khatchadourian V; Zou M; Li W; De Filippo R; Kokorowski P; Chang A; Kim S; Bertoni A; Furlanetto TW; Shin S; Li M; Chen Y; Wong A; Koh C; Geliebter J; Hong YK
Cancer Res; 2016 Feb; 76(3):582-93. PubMed ID: 26609053
[TBL] [Abstract][Full Text] [Related]
2. LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma.
Zhao S; Wang Q; Li Z; Ma X; Wu L; Ji H; Qin G
J Exp Clin Cancer Res; 2015 Dec; 34():146. PubMed ID: 26637328
[TBL] [Abstract][Full Text] [Related]
3. KSR1 is coordinately regulated with Notch signaling and oxidative phosphorylation in thyroid cancer.
Lee J; Seol MY; Jeong S; Kwon HJ; Lee CR; Ku CR; Kang SW; Jeong JJ; Shin DY; Nam KH; Lee EJ; Chung WY; Jo YS
J Mol Endocrinol; 2015 Apr; 54(2):115-24. PubMed ID: 25608512
[TBL] [Abstract][Full Text] [Related]
4. RASSF10 is Epigenetically Inactivated and Suppresses Cell Proliferation and Induces Cell Apoptosis by Activating the p53 Signalling Pathway in Papillary Thyroid Carcinoma Cancer.
Fan C; Wang W; Jin J; Yu Z; Xin X
Cell Physiol Biochem; 2017; 41(3):1229-1239. PubMed ID: 28268222
[TBL] [Abstract][Full Text] [Related]
5. Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt/β-catenin signaling.
Zhang X; Li M; Zuo K; Li D; Ye M; Ding L; Cai H; Fu D; Fan Y; Lv Z
J Clin Endocrinol Metab; 2013 Aug; 98(8):E1305-13. PubMed ID: 23796566
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profile analyze the molecular mechanism of CXCR7 regulating papillary thyroid carcinoma growth and metastasis.
Zhang H; Teng X; Liu Z; Zhang L; Liu Z
J Exp Clin Cancer Res; 2015 Feb; 34(1):16. PubMed ID: 25887589
[TBL] [Abstract][Full Text] [Related]
7. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
Ma Y; Qin H; Cui Y
Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341
[TBL] [Abstract][Full Text] [Related]
8. Transcription Factor Prospero Homeobox 1 (PROX1) as a Potential Angiogenic Regulator of Follicular Thyroid Cancer Dissemination.
Rudzińska M; Mikula M; Arczewska KD; Gajda E; Sabalińska S; Stępień T; Ostrowski J; Czarnocka B
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717665
[TBL] [Abstract][Full Text] [Related]
9. ZNRF3 is downregulated in papillary thyroid carcinoma and suppresses the proliferation and invasion of papillary thyroid cancer cells.
Qiu W; Yang Z; Fan Y; Zheng Q
Tumour Biol; 2016 Sep; 37(9):12665-12672. PubMed ID: 27448298
[TBL] [Abstract][Full Text] [Related]
10. Transcription Factor PROX1 Suppresses Notch Pathway Activation via the Nucleosome Remodeling and Deacetylase Complex in Colorectal Cancer Stem-like Cells.
Högström J; Heino S; Kallio P; Lähde M; Leppänen VM; Balboa D; Wiener Z; Alitalo K
Cancer Res; 2018 Oct; 78(20):5820-5832. PubMed ID: 30154153
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt/β-catenin signaling pathway.
Zhou Z; Liu Y; Ma M; Chang L
Biomed Pharmacother; 2017 Dec; 96():98-103. PubMed ID: 28965013
[TBL] [Abstract][Full Text] [Related]
12. PROX1 Promotes Secretory Granule Formation in Medullary Thyroid Cancer Cells.
Ishii J; Yazawa T; Chiba T; Shishido-Hara Y; Arimasu Y; Sato H; Kamma H
Endocrinology; 2016 Mar; 157(3):1289-98. PubMed ID: 26760117
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of Dickkopf-1 in wild-type BRAF papillary thyroid cancer via regulation of β-catenin/E-cadherin signaling.
Cho SW; Kim YA; Sun HJ; Ahn HY; Lee EK; Yi KH; Oh BC; Park DJ; Cho BY; Park YJ
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1641-9. PubMed ID: 24848709
[TBL] [Abstract][Full Text] [Related]
14. Notch and TGF-β/Smad3 pathways are involved in the interaction between cancer cells and cancer-associated fibroblasts in papillary thyroid carcinoma.
Zhang J; Wang Y; Li D; Jing S
Tumour Biol; 2014 Jan; 35(1):379-85. PubMed ID: 23918305
[TBL] [Abstract][Full Text] [Related]
15. Yes-associated protein 1 promotes papillary thyroid cancer cell proliferation by activating the ERK/MAPK signaling pathway.
Liao T; Wen D; Ma B; Hu JQ; Qu N; Shi RL; Liu L; Guan Q; Li DS; Ji QH
Oncotarget; 2017 Feb; 8(7):11719-11728. PubMed ID: 28036290
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of Wnt signaling pathway gene SRY-related HMG-box 17 in papillary thyroid carcinoma.
Li JY; Han C; Zheng LL; Guo MZ
Chin Med J (Engl); 2012 Oct; 125(19):3526-31. PubMed ID: 23044318
[TBL] [Abstract][Full Text] [Related]
17. Methylation of DACT2 promotes papillary thyroid cancer metastasis by activating Wnt signaling.
Zhao Z; Herman JG; Brock MV; Sheng J; Zhang M; Liu B; Guo M
PLoS One; 2014; 9(11):e112336. PubMed ID: 25375359
[TBL] [Abstract][Full Text] [Related]
18. LGR5 is associated with tumor aggressiveness in papillary thyroid cancer.
Michelotti G; Jiang X; Sosa JA; Diehl AM; Henderson BB
Oncotarget; 2015 Oct; 6(33):34549-60. PubMed ID: 26416247
[TBL] [Abstract][Full Text] [Related]
19. miR-182 targets CHL1 and controls tumor growth and invasion in papillary thyroid carcinoma.
Zhu H; Fang J; Zhang J; Zhao Z; Liu L; Wang J; Xi Q; Gu M
Biochem Biophys Res Commun; 2014 Jul; 450(1):857-62. PubMed ID: 24971532
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated siRNA targeting NOB1 inhibits tumor growth and enhances radiosensitivity of human papillary thyroid carcinoma in vitro and in vivo.
Meng W; Wang PS; Liu J; Xue S; Wang GM; Meng XY; Chen G
Oncol Rep; 2014 Dec; 32(6):2411-20. PubMed ID: 25231838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]